Abstract
Objective and design
We studied five cases of PID-related monogenic lupus to explore the characteristics.
Material or subjects
Among 42 cases of PID patients between 2017–2020, 5 patients were diagnosed as PID-related monogenic lupus, including 2 males and 3 females, with age range from 2 years 3 months to 13 years old.
Treatments
DMARDs, biological agents and stem cell transplantation were used to treat different patients.
Methods
We collected the clinical observation indicators, auxiliary examination and treatment of the five patients.
Results
Patient 1 was diagnosed with monogenic lupus secondary to severe combined immunodeficiency and received prednisone and methotrexate treatment. Patient 2 was diagnosed with monogenic lupus secondary to activated phosphoinositide 3-kinase δ syndrome. Allogeneic stem cell transplantation was conducted. Patient 3 was diagnosed with monogenic lupus secondary to RAS‐associated lymphoproliferative disease. The child was treated with prednisone and rituximab. Patient 4 was diagnosed with monogenic lupus secondary to PSTPIP1-associated myeloid-related proteinaemia inflammatory syndrome. The child was given methylprednisolone, methotrexate, and infliximab. Patient 5 was diagnosed with monogenic lupus secondary to A20 haploinsufficiency. The child was treated with methylprednisolone and infliximab.
Conclusions
Multiple PIDs can lead to monogenic lupus. Different PID-related monogenic lupus has different suitable targeted drugs.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
Availability of data and materials
Please contact authors for data requests.
References
Errante PR, Perazzio SF, Frazao JB, et al. Primary Immunodeficiency association with systemic lupus erythematosus: review of literature and lessons learned by the Rheumatology Division of a teriary university hospital at Sao Paulo, Brazil. Rev Bras Reumatol. 2016;56(1):58–68.
Tangye SG, Al-Herz W, Bousfiha A, et al. Human inborn errors of immunity: 2019 update on the classification from the international union of immunological societies expert committee. J Clin Immunol. 2020;40:24–64.
Giardino G, Gallo V, Prencipe R, Gaudino G, Romano R, De Cataldis M, Lorello P, Palamaro L, Di Giacomo C, Capalbo D, Cirillo E, D’Assante R, Pignata C. Unbalanced immune system: immunodeficiencies and autoimmunity. Front Pediatr. 2016;4:107. https://doi.org/10.3389/fped.2016.00107.
Almlöf JC, Nystedt S, Leonard D, Eloranta ML, Grosso G, Sjöwall C, Bengtsson AA, Jönsen A, Gunnarsson I, Svenungsson E, et al. Whole-genome sequencing identifies complex contributions to genetic risk by variants in genes causing monogenic systemic lupus erythematosus. Hum Genet. 2019;138(2):141–50 (Epub 2019 Feb 1).
Demirkaya E, Sahin S, Romano M, Zhou Q, Aksentijevich I. New horizons in the genetic etiology of systemic lupus erythematosus and lupus-like disease: monogenic lupus and beyond. J Clin Med. 2020;9(3):712. https://doi.org/10.3390/jcm9030712.
Hochberg MC. Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum. 1997;40(9):1725–6.
Petri M, Orbai AM, Alarcon GS, et al. Derivation and validation of the systemic lupus international collaborating clinics classification criteria for systemic lupus erythematosus. Arthritis Rheum. 2012;64(8):2677–86.
Farmer JR, Foldvari Z, Ujhazi B, De Ravin SS, Chen K, Bleesing JJH, et al. Outcomes and treatment strategies for autoimmunity and hyperinflammation in patients with RAG deficiency. J Allergy Clin Immunol Pract. 2019;7(6):1970-1985.e4. https://doi.org/10.1016/j.jaip.2019.02.038 (Epub 2019 Mar 12).
Chen K, Wu W, Mathew D, Zhang Y, Browne SK, Rosen LB, McManus MP, Pulsipher MA, Yandell M, Bohnsack JF, et al. Autoimmunity due to RAG deficiency and estimated disease incidence in RAG1/2 mutations. J Allergy Clin Immunol. 2014;133:880-882.e810 (CrossRef PubMed).
Walter JE, Lo MS, Kis-Toth K, Tirosh I, Frugoni F, Lee YN, et al. Impaired receptor editing and heterozygous RAG2 mutation in a patient with systemic lupus erythematosus and erosive arthritis. J Allergy Clin Immunol. 2015;135:272–3.
Coulter TI, Chandra A, Bacon CM, et al. Clinical spectrum and features of activated phosphoinositide 3-kinaseδsyndrome: a large cohort study. Allergy Clin Immunol. 2017;139(2):597–606.
Wang W, Zhou Y, Zhong L, Wang L, Tang X, Ma M, Li J, Song H, Wang W, et al. RAS-associated autoimmune leukoproliferative disease (RALD) manifested with early-onset SLE-like syndrome: a case series of RALD in Chinese children. Pediatr Rheumatol Online J. 2019;17(1):55. https://doi.org/10.1186/s12969-019-0346-1.
Holzinger D, Fassl SK, de Jager W, Lohse P, Rohrig UF, Gattorno M, et al. Single amino acid charge switch defines clinically distinct proline-serine-threonine phosphatase-interacting protein 1 (PSTPIP1)-associated inflammatory diseases. J Allergy Clin Immunol. 2015;136:1337–45. https://doi.org/10.1016/j.jaci.2015.04.016.
Oda H, Kastner DL. Genomics, biology, and human illness: advances in the monogenic autoinflammatory diseases. Rheum Dis Clin N Am. 2017;43(3):327–45. https://doi.org/10.1016/j.rdc.2017.04.011.
Aeschlimann FA, Batu ED, Canna SW, Go E, Gül A, Hoffmann P, Leavis HL, Ozen S, Schwartz DM, Stone DL, van Royen-Kerkof A, Kastner DL, Aksentijevich I, Laxer RM. A20 haploinsufficiency (HA20): clinical phenotypes and disease course of patients with a newly recognised NF-kB-mediated autoinflammatory disease. Ann Rheum Dis. 2018;77(5):728–35. https://doi.org/10.1136/annrheumdis-2017-212403.
Kadowaki T, Ohnishi H, Kawamoto N, Hori T, Nishimura K, Kobayashi C, Shigemura T, Ogata S, Inoue Y, Kawai T, Hiejima E, Takagi M, Imai K, Nishikomori R, Ito S, Heike T, Ohara O, Morio T, Fukao T, Kanegane H. Haploinsufficiency of A20 causes autoinflammatory and autoimmune disorders. J Allergy Clin Immunol. 2018;141(4):1485-1488.e11. https://doi.org/10.1016/j.jaci.2017.10.039.
Rao VK, Dugan F, Dale JK, et al. Use of mycophenolate mofetil for chronic, refractory immune cyLopenias in children with auloim-mune lymphoproliferative syndrome. Br J Haemat. 2005;01(129):534–8.
Teachey DT, Creiner R, Seif A, et al. Treatment with sirolimus results in complete responses in patients with autoimmune lympho-proliferative syndrome. Br J Haemat. 2009;01(145):101–6.
Cooper N, Davies EC, Thrasher AJ. Repeated courses of rituximab for autoimmune cytopenias may precipitate profound hypoga-mmaglobulinaemia requiring replacement intravenous immunoglobulin. Br J Haematol. 2009;146:120–2.
Funding
The National Natural Science Fund of China: 81701618/H1008.
Author information
Authors and Affiliations
Contributions
GS diagnosed the patients, designed the project and wrote the manuscript; JZ, DZ, JH, YX and XW participated in clinical care and recorded clinical data; ZZ diagnosed the patients and supervised the project; JL supervised the project, wrote and revised the manuscript. All authors read and approved the final manuscript.
Corresponding author
Ethics declarations
Ethics approval
Approved by the Institute Review Board of Capital Institute of Pediatrics.
Consent to participate
Approved by the Institute Review Board of Capital Institute of Pediatrics.
Conflict of interest
The authors declare that they have no competing interests.
Additional information
Communicated by John Di Battista.
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Supplementary Information
Below is the link to the electronic supplementary material.
Rights and permissions
About this article
Cite this article
Su, G., Lai, J., Zhu, J. et al. Analysis of five cases of monogenic lupus related to primary immunodeficiency diseases. Inflamm. Res. 70, 1211–1216 (2021). https://doi.org/10.1007/s00011-021-01479-6
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00011-021-01479-6